Hologic, Inc.  

(Public, NASDAQ:HOLX)   Watch this stock  
Find more results for holx
-0.25 (-0.63%)
Jan 20 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 39.31 - 39.85
52 week 31.84 - 41.01
Open 39.77
Vol / Avg. 1.78M/2.43M
Mkt cap 10.88B
P/E 34.02
Div/yield     -
EPS 1.16
Shares 278.22M
Beta 1.17
Inst. own 100%
Mar 8, 2017
Hologic Inc Annual Shareholders Meeting - 8:00AM EST - Add to calendar
Mar 2, 2017
Hologic Inc Annual Shareholders Meeting (Estimated) - 8:00AM EST - Add to calendar
Jan 25, 2017
Q1 2017 Hologic Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Jan 10, 2017
Hologic Inc at JPMorgan Healthcare Conference
Dec 14, 2016
Hologic Inc Conference Call to Discuss on Blood Screening Divestiture
Nov 30, 2016
Hologic Inc at Piper Jaffray Healthcare Conference - Webcast
Nov 17, 2016
Hologic Inc at Canaccord Genuity Med Tech Conference
Nov 16, 2016
Hologic Inc at Stifel Healthcare Conference
Nov 2, 2016
Q4 2016 Hologic Inc Earnings Call - Webcast
Nov 2, 2016
Q4 2016 Hologic Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2016
Net profit margin 12.67% 11.68%
Operating margin 20.11% 19.18%
EBITD margin - 36.16%
Return on average assets 5.05% 4.42%
Return on average equity 17.65% 15.67%
Employees 5,333 -
CDP Score - -


250 Campus Dr
MARLBOROUGH, MA 01752-3020
United States - Map
+1-508-2632900 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays. It offers viral load assays for the quantitation of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus-1 (HIV-1). The Breast Health products include breast imaging and related products and accessories, including digital mammography systems, computer-aided detection (CAD) and breast biopsy guidance systems. The GYN Surgical products include NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment offers Discovery and Horizon X-ray bone densitometers and mini C-arm imaging systems.

Officers and directors

Stephen P. MacMillan Chairman of the Board, President, Chief Executive Officer
Age: 52
Bio & Compensation  - Reuters
Robert W. McMahon Chief Financial Officer
Age: 47
Bio & Compensation  - Reuters
Sanjay Prabhakaran Regional President - Asia
Bio & Compensation  - Reuters
Peter J. Valenti III Division President- Breast and Skeletal Health
Age: 52
Bio & Compensation  - Reuters
Jan Verstreken Regional President - Europe,Middle EastandAfrica(EMEA) and Canada
Bio & Compensation  - Reuters
Thomas A. West Division President- Diagnostics
Age: 52
Bio & Compensation  - Reuters
Eric Compton Chief Operating Officer
Age: 51
Bio & Compensation  - Reuters
Jay A. Stein Chairman Emeritus, Senior Vice President & Chief Technical Officer
Age: 73
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Allison Bebo Senior Vice President - Human Resources
Bio & Compensation  - Reuters
John M. Griffin General Counsel
Age: 55
Bio & Compensation  - Reuters